Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
44.34
+3.35 (8.17%)
At close: Oct 27, 2025, 4:00 PM EDT
44.31
-0.03 (-0.07%)
After-hours: Oct 27, 2025, 6:56 PM EDT
Crinetics Pharmaceuticals Employees
Crinetics Pharmaceuticals had 437 employees as of December 31, 2024. The number of employees increased by 147 or 50.69% compared to the previous year.
Employees
437
Change (1Y)
147
Growth (1Y)
50.69%
Revenue / Employee
$3,185
Profits / Employee
-$846,302
Market Cap
4.18B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 437 | 147 | 50.69% |
| Dec 31, 2023 | 290 | 80 | 38.10% |
| Dec 31, 2022 | 210 | 67 | 46.85% |
| Dec 31, 2021 | 143 | 50 | 53.76% |
| Dec 31, 2020 | 93 | 25 | 36.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CRNX News
- 4 days ago - Crinetics to Highlight Neuroendocrine Tumor Research Progress at the 2025 North American Neuroendocrine Tumor Society Annual Meeting - GlobeNewsWire
- 17 days ago - Crinetics Pharmaceuticals Announces October 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 21 days ago - Crinetics Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025 - GlobeNewsWire
- 4 weeks ago - Crinetics: FDA Approval And Expansion Of Palsonify In Focus, Maintaining 'Buy' Rating - Seeking Alpha
- 4 weeks ago - Crinetics Pharmaceuticals, Inc. - Special Call - Seeking Alpha
- 4 weeks ago - Crinetics Announces FDA Approval of PALSONIFY™ (paltusotine) for the Treatment of Adults with Acromegaly - GlobeNewsWire
- 6 weeks ago - Crinetics Pharmaceuticals Announces September 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Crinetics Receives FDA Orphan Drug Designation for Atumelnant in the Treatment of Congenital Adrenal Hyperplasia (CAH) - GlobeNewsWire